Biden may want to continue the previous administration’s efforts to lower drug prices and make medical costs transparent.
By Elisabeth Rosenthal
Dr. Rosenthal was an emergency room physician before becoming a journalist. A former New York Times correspondent, she is the author of “An American Sickness: How Healthcare Became Big Business and How You Can Take It Back” and the editor in chief of Kaiser Health News.
President Biden’s goal of providing health care for more Americans advanced this week with Mr. Biden’s signing of an economic stimulus package that includes subsidies for health insurance premiums and new incentives for states to expand Medicaid, as well as the potential confirmation of Xavier Becerra as secretary of health and human services.
But as the current administration works to reverse the actions of its predecessor, it should recognize that former President Donald Trump introduced some policies on medical care and drug price transparency that are worth preserving. Those measures could help struggling patient-consumers while the new administration pushes for the far more ambitious reforms Mr. Biden campaigned on, which include a public health insurance option and a system that would allow Medicare to negotiate drug prices.
To be clear, the Trump administration, generally, put the health care of many Americans in jeopardy: It spent four years trying to overturn the Affordable Care Act, despite that law’s undeniable successes, and when repeal proved impossible, kneecapped the program in countless ways. As a result of those policies, more than two million people lost health insurance during Mr. Trump’s first three years. And that’s before millions more people lost their jobs and accompanying insurance during the early days of the Covid-19 pandemic.
But the Trump administration did attempt to rein in some of the most egregious pricing in the health care industry. For example, it required most hospitals to post lists of their standard prices for supplies, drugs, tests and procedures. Providers had long resisted calls for such pricing transparency, arguing that this was a burden, and that since insurers negotiated and paid far lower rates anyway, those list prices didn’t really matter.
Of course, prices do matter to the patients who are uninsured or end up at an out-of-network hospital when illness strikes and are charged full freight, or nearly so. Some patients, facing bills of hundreds of thousands of dollars, have been sued by hospitals or forced into bankruptcy or foreclosure.
In 2019, the Trump administration proposed a rule that hospitals disclose the discounted rates that they agree to accept from insurers for common medical services, as well as prices for patients who pay in cash. To be clear, this type of transparency doesn’t directly lower bills, but the information can help patients shop around for medical care.
These master price lists span hundreds of pages and are hard to decipher. Nonetheless, they give consumers a basis to fight back against outrageous charges in a system where a knee replacement can cost $15,000 or $75,000 even at the same hospital. And the requirement might just motivate some providers to lower their prices, if only to compete with neighboring hospitals.
Last summer hospitals said it was too hard to comply with the new rule while they were dealing with the pandemic. They still managed to continue the appeal of their lawsuit against the measure, which failed in December. The rule took effect, but the penalty for not complying is just $300 a day — a pittance for hospitals — and there is no meaningful mechanism for active enforcement. The hospitals have asked the Biden administration to revise the requirement.
Mr. Trump also used his bully pulpit to take on drug prices, remarking at his first news conference as president-elect that pharmaceutical manufacturers were “getting away with murder.” His administration ordered drug makers to list prices in advertisements for medications that cost more than $35 per month. (Some of the most commonly advertised drugs cost thousands of dollars.) Just before the order took effect, a court blocked it.
Then, last summer, Mr. Trump issued a bunch of executive orders aimed at forcing drug price reductions. In September his health secretary, Alex Azar, certified that importing prescription medicine from Canada “poses no additional risk to the public’s health and safety” and would result in “a significant reduction in the cost.” This statement, which previous health secretaries had declined to make, formally opened the door to importing medication. Millions of Americans, meanwhile, now illegally purchase prescription drugs from abroad because they cannot afford to buy them at home.
Source: Read Full Article